Targeted Therapy in Breast Cancer
Top Cited Papers
Open Access
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 3 (4), 379-398
- https://doi.org/10.1074/mcp.r400001-mcp200
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapyEuropean Journal Of Cancer, 2003
- Male Breast Carcinoma: Correlation of ER, PR, Ki-67, Her2-Neu, and p53 with Treatment and Survival, a Study of 65 CasesLaboratory Investigation, 2002
- TrastuzumabDrugs, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Serial serum c-erbB-2 levels in patients with breast carcinomaCancer, 1996
- Plasma c-erbB2 concentrations in relation to chemotherapy in breast cancer patientsEuropean Journal Of Cancer, 1996
- Prognostic Factors for Carcinoma of the Male BreastInternational Journal of Surgical Pathology, 1995
- Long‐term survival in breast cancer related to overexpression of the c‐erbB‐2 oncoprotein: An immunohistochemical study using monoclonal antibody NCL‐CB11The Journal of Pathology, 1991
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987